Biao Yan
Chief Executive Officer bij ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Profiel
Biao Yan is currently the Chairman & General Manager at Zhejiang Shapuaisi Pharmaceutical Co. Ltd.
and Chairman at Shapuaisi Qiangshen Pharma Co., Ltd.
He completed his undergraduate degree at Shanghai Jiao Tong University.
Actieve functies van Biao Yan
| Bedrijven | Functie | Begin |
|---|---|---|
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Chief Executive Officer | 10-05-2021 |
Shapuaisi Qiangshen Pharma Co., Ltd.
 Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The private company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Chairman | - |
Opleiding van Biao Yan
| Shanghai Jiao Tong University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The private company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Health Technology |
